Literature DB >> 11243407

The role of NF-kappaB in the regulation of the expression of wilms tumor suppressor gene WT1.

Y Chen1, B R Williams.   

Abstract

The Wilms tumor suppressor gene, WT1, plays an important role in genitourinary development and the etiology of Wilms tumor. WT1 has a spatially and temporally defined expression in the developing genitourinary system and in specific cells of the hematopoietic system, but the regulatory pathways that control WT1 expression are not well understood. Recently, members of the NF-kappaB family of transcription factors have been proposed as potent activators of the murine WT1 promoter through binding to a NF-kappaB site. Because the human WT1 promoter contains a conserved NF-kappaB site, we investigated whether NF-kappaB also regulates the expression of the human WT1 gene. We activated NF-kappaB through cytokine stimulation or inhibited NF-kappaB through expression of a NF-kappaB "super repressor" in WT1 expressing Wilms tumor, renal carcinoma, and erythroleukemia cultures and examined the level of endogenous WT1 gene expression. Although a transfected NF-kappaB reporter construct was responsive to these manipulations, we found that altering NF-kappaB activity had no effect on endogenous WT1 expression in the cell types used in our study. We conclude that despite the presence of conserved NF-kappaB elements in the murine and human WT1 promoters, NF-kappaB is not required to regulate the expression of the WT1 gene in its natural context.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11243407      PMCID: PMC5964932          DOI: 10.3727/000000001783992614

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  51 in total

1.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

Review 2.  The genetics of Wilms' tumor--a case of disrupted development.

Authors:  N D Hastie
Journal:  Annu Rev Genet       Date:  1994       Impact factor: 16.830

Review 3.  Molecular genetic pathways to Wilms tumor.

Authors:  K Pritchard-Jones
Journal:  Crit Rev Oncog       Date:  1997

4.  Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.

Authors:  A A Beg; T S Finco; P V Nantermet; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

5.  Simian virus 40 small-t does not transactivate RNA polymerase II promoters in virus infections.

Authors:  P Rajan; V Dhamankar; K Rundell; B Thimmapaya
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

Authors:  T Henkel; T Machleidt; I Alkalay; M Krönke; Y Ben-Neriah; P A Baeuerle
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

7.  RNA expression of the WT1 gene in Wilms' tumors in relation to histology.

Authors:  H Miwa; G E Tomlinson; C F Timmons; V Huff; S L Cohn; L C Strong; G F Saunders
Journal:  J Natl Cancer Inst       Date:  1992-02-05       Impact factor: 13.506

8.  Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.

Authors:  S Swaminathan; B Thimmapaya
Journal:  J Mol Biol       Date:  1996-05-24       Impact factor: 5.469

9.  Precocious expression of the Wilms' tumor gene xWT1 inhibits embryonic kidney development in Xenopus laevis.

Authors:  J B Wallingford; T J Carroll; P D Vize
Journal:  Dev Biol       Date:  1998-10-01       Impact factor: 3.582

10.  Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues.

Authors:  S Mundlos; J Pelletier; A Darveau; M Bachmann; A Winterpacht; B Zabel
Journal:  Development       Date:  1993-12       Impact factor: 6.868

View more
  2 in total

1.  The role of NF-κB signaling in the maintenance of pluripotency of human induced pluripotent stem cells.

Authors:  Osamu Takase; Masahiro Yoshikawa; Mana Idei; Junichi Hirahashi; Toshiro Fujita; Tsuyoshi Takato; Takayuki Isagawa; Genta Nagae; Hirofumi Suemori; Hiroyuki Aburatani; Keiichi Hishikawa
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

2.  Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde.

Authors:  Ning Wang; Hor-Yue Tan; Yau-Tuen Chan; Wei Guo; Sha Li; Yibin Feng
Journal:  Oncotarget       Date:  2017-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.